HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils.

AuthorsE M Lumb, G J McHardy, A B Kay
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 8 Issue 1 Pg. 65-74 (Jul 1979) ISSN: 0306-5251 [Print] England
PMID121884 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Histamine Antagonists
  • Indans
  • Indenes
  • nivimedone
  • Immunoglobulin E
  • Complement System Proteins
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Asthma (drug therapy)
  • Clinical Trials as Topic
  • Complement System Proteins (analysis)
  • Eosinophils (drug effects)
  • Female
  • Histamine Antagonists (pharmacology, therapeutic use)
  • Humans
  • Immunoglobulin E (analysis)
  • Indans (pharmacology, therapeutic use)
  • Indenes (therapeutic use)
  • Leukocyte Count
  • Male
  • Maximal Expiratory Flow Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: